Examination Report |
1 | Additional Representation Sheet | 29 Apr 2015 |
2 | TM-1 | 29 Apr 2015 |
3 | Reply to Exam Report (MIS-R) | 19 Jul 2016 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 23 Jan 2018 |
5 | Journal Copy | 29 Aug 2018 |
6 | TM-O(NOTICE OF OPPOSITION) | 23 Oct 2018 |
7 | Annexure -1 under rule 46 | 20 Dec 2019 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 20 Dec 2019 |
8 | Annexure -1 under rule 46 | 20 Dec 2019 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 20 Dec 2019 |
9 | Letters related to TOP | 10 Feb 2020 |
1 | Dispatching of Examination Report for : 2951981 | 3688106 | 1835223 | 27 Jun 2016 |
2 | Hearing Notice (Show Cause) | 6440017 | 2952817 | 30 May 2018 |
3 | Tribunal Accepted Notice for : 2951981 | 6643259 | 2994008 | 11 Jul 2018 |
4 | Opposition Notice | 8271048 | 4064970 | 16 May 2019 |
5 | Opposition Notice | 8595505 | 4243828 | 15 Jul 2019 |
6 | Opposition Counter Statement | 8629459 | 4260397 | 22 Jul 2019 |
Trademark was applied on 29 April 2015 with IP India.
Proprietor of Femikare is Torrent Pharmaceuticals Limited.
Class(es) in which the trademark was applied to is 3.
Status of Femikare is Opposed.
Application number alloted to the trademark is 2951981.
Krishna And Saurastri Associates Llp is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD